`
`From: Beel, Bryan D. (Perkins Coie) <BBeel@perkinscoie.com>
`Sent: Monday, November 20, 2023 3:43 PM
`To: Megan Raymond <megan.raymond@groombridgewu.com>
`Cc: Novo-Semaglutide-IPR@groombridgewu.com; White, Brandon (Perkins Coie)
`<BMWhite@perkinscoie.com>; White-ptab@perkinscoie.com; Greb-ptab@perkinscoie.com;
`prochnow-ptab@perkinscoie.com; jones-ptab@perkinscoie.com; tietz-ptab@perkinscoie.com;
`lembo-ptab@perkinscoie.com; Semaglutide-Ozempic@perkinscoie.com; Beel, Bryan D. (Perkins
`Coie) <BBeel@perkinscoie.com>
`Subject: RE: IPR2023-00724
`
`Megan,
`
`Mylan does not agree to provide a Sotera stipulation. The trial date in the Ozempic district court
`litigation was ordered in June 2022 (22-cv-294, DI 22) and was explicitly disclosed and discussed in
`the Petition (Pet. at 65; Ex. 1082 (Scheduling Order)). Mylan addressed Fintiv in its Petition, yet the
`Patent Owner chose not to address that issue in its Preliminary Response. Moreover, the time to
`seek rehearing of the institution decision passed a month ago, and there has been no joinder of any
`proceeding with Mylan’s Petition, so there are no “new facts” to address. We can be available to
`meet and confer on November 22, if necessary. To the extent Novo intends to seek any relief from
`the Board, please provide your position before contacting the Board so we may add Mylan’s position.
`
`Best regards,
`Bryan
`
`Bryan Beel, Ph.D. | Perkins Coie LLP
`SENIOR COUNSEL
`1120 N.W. Couch Street Tenth Floor
`Portland, OR 97209-4128
`D. +1.503.727.2116
`F. +1.503.346.2116
`E. BBeel@perkinscoie.com
`
`
`
`
`
`From: Megan Raymond <megan.raymond@groombridgewu.com>
`Sent: Thursday, November 16, 2023 11:44 AM
`To: White, Brandon (WDC) <BMWhite@perkinscoie.com>; *White-ptab <White-
`ptab@perkinscoie.com>; *Greb-ptab <Greb-ptab@perkinscoie.com>; *prochnow-ptab <prochnow-
`ptab@perkinscoie.com>; *Jones-ptab <jones-ptab@perkinscoie.com>; *tietz-ptab <tietz-
`ptab@perkinscoie.com>; *lembo-ptab <lembo-ptab@perkinscoie.com>; *Semaglutide-Ozempic
`<Semaglutide-Ozempic@perkinscoie.com>
`Cc: Novo-Semaglutide-IPR@groombridgewu.com
`Subject: IPR2023-00724
`
`
`Novo Nordisk Exhibit 2540
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00001
`
`
`
`Counsel,
`
`
`
`Since the time of institution of the ‘462 IPR, two copycat petitions have been filed (which would
`remove the one-year statutory deadline for the issuance of the final written decision in Mylan’s IPR)
`and Mylan’s ‘462 trial date has been set for September 30, 2024. In view of these circumstances,
`and the Fintiv issues that are now implicated, we write to ask whether Mylan would agree to provide
`a Sotera stipulation rather than just the Sand Revolution stipulation it previously furnished. Please let
`us know by Monday, and whether you wish to have a telephonic meet and confer. If Mylan is not
`amenable to providing a Sotera stipulation, Petitioner will seek leave to file a request for rehearing
`now to brief Fintiv issues in view of the latest facts, and request that the IPR be uninstituted.
`
` Sincerely,
` Megan Raymond
`
`
`
`This message is intended only for the use of the addressee and may contain confidential and
`privileged information. Any review, use, or dissemination by anyone other than the addressee is s
`strictly prohibited. If you received this message in error, please notify us and delete all copies of this
` message.
`
`
`
`
`Novo Nordisk Exhibit 2540
`Mylan Pharms. Inc. v. Novo Nordisk A/S
`IPR2023-00724
`Page 00002
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
